Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 465 * ! | Wed, 8/7/2013, 8:30 AM - 10:20 AM | CC-510a | |
| Highlights of a Special Issue of SBR in Honor of Robert O'Neill's Tenure as Director of the Office of Biostatistics at FDA — Invited Papers | |||
| Statistics in Biopharmaceutical Research Journal , Biopharmaceutical Section | |||
| Organizer(s): Steven Snapinn, Amgen | |||
| Chair(s): Steven Snapinn, Amgen | |||
| 8:35 AM | The Contributions of Robert T. O'Neill to the Evolution of Regulatory Statistical Science — Charles Anello, Applied Statistical Concepts, LLC ; Suzanne Junod, US FDA Office of Public Information and Library Servics, FDA History Office | ||
| 9:00 AM | Advances in Biopharmaceutical Statistical Science Applied to Safety During Dr. O'Neill's Tenure — Frank W. Rockhold, GlaxoSmithKline | ||
| 9:25 AM | Unblinded Adaptive Statistical Information Designs: Clinical Endpoint With or Without Biomarker — Sue-Jane Wang, Food and Drug Administration | ||
| 9:50 AM | Discussant: Robert Thomas O'Neill, FDA | ||
| 10:10 AM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.